388 related articles for article (PubMed ID: 8965097)
1. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.
Reifenberger J; Ring GU; Gies U; Cobbers L; Oberstrass J; An HX; Niederacher D; Wechsler W; Reifenberger G
J Neuropathol Exp Neurol; 1996 Jul; 55(7):822-31. PubMed ID: 8965097
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.
Cheng Y; Ng HK; Ding M; Zhang SF; Pang JC; Lo KW
J Neuropathol Exp Neurol; 1999 Feb; 58(2):120-8. PubMed ID: 10029095
[TBL] [Abstract][Full Text] [Related]
3. [Study on the expression of epidermal growth factor receptor and p53 in astrocytic gliomas: evidence for a distinct genetic pathway].
Dong L; Pu PY; Wang H; Wang GX; Kang CS; Jiao DR
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):232-6. PubMed ID: 16776982
[TBL] [Abstract][Full Text] [Related]
4. p53 protein and epidermal growth factor receptor expression in human astrocytomas.
Kordek R; Biernat W; Alwasiak J; Maculewicz R; Yanagihara R; Liberski PP
J Neurooncol; 1995 Oct; 26(1):11-6. PubMed ID: 8583240
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.
Watanabe K; Tachibana O; Sata K; Yonekawa Y; Kleihues P; Ohgaki H
Brain Pathol; 1996 Jul; 6(3):217-23; discussion 23-4. PubMed ID: 8864278
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of molecular alterations in microdissected archival gliomas.
Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
[TBL] [Abstract][Full Text] [Related]
7. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
Ohgaki H; Kleihues P
J Neuropathol Exp Neurol; 2005 Jun; 64(6):479-89. PubMed ID: 15977639
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations in pediatric high-grade astrocytomas.
Cheng Y; Ng HK; Zhang SF; Ding M; Pang JC; Zheng J; Poon WS
Hum Pathol; 1999 Nov; 30(11):1284-90. PubMed ID: 10571506
[TBL] [Abstract][Full Text] [Related]
9. Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas.
Waha A; Baumann A; Wolf HK; Fimmers R; Neumann J; Kindermann D; Astrahantseff K; Blümcke I; von Deimling A; Schlegel U
J Neurosurg; 1996 Oct; 85(4):634-41. PubMed ID: 8814167
[TBL] [Abstract][Full Text] [Related]
10. [Mutation of isocitrate dehydrogenase gene in Chinese patients with glioma].
Pan Y; Qi XL; Wang LM; Dong RF; Zhang M; Zheng DF; Chang Q; Zhong YF
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):292-8. PubMed ID: 24004584
[TBL] [Abstract][Full Text] [Related]
11. p53 mutations versus EGF receptor expression in giant cell glioblastomas.
Peraud A; Watanabe K; Plate KH; Yonekawa Y; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1236-41. PubMed ID: 9370234
[TBL] [Abstract][Full Text] [Related]
12. p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression.
van Meyel DJ; Ramsay DA; Casson AG; Keeney M; Chambers AF; Cairncross JG
J Natl Cancer Inst; 1994 Jul; 86(13):1011-7. PubMed ID: 8007011
[TBL] [Abstract][Full Text] [Related]
13. Expression of neu/c-erbB-2 in human brain tumors.
Schwechheimer K; Läufle RM; Schmahl W; Knödlseder M; Fischer H; Höfler H
Hum Pathol; 1994 Aug; 25(8):772-80. PubMed ID: 7914508
[TBL] [Abstract][Full Text] [Related]
14. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
[TBL] [Abstract][Full Text] [Related]
15. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
[TBL] [Abstract][Full Text] [Related]
16. PTEN gene mutations are seen in high-grade but not in low-grade gliomas.
Rasheed BK; Stenzel TT; McLendon RE; Parsons R; Friedman AH; Friedman HS; Bigner DD; Bigner SH
Cancer Res; 1997 Oct; 57(19):4187-90. PubMed ID: 9331072
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations.
Zhou XP; Li YJ; Hoang-Xuan K; Laurent-Puig P; Mokhtari K; Longy M; Sanson M; Delattre JY; Thomas G; Hamelin R
Int J Cancer; 1999 Apr; 84(2):150-4. PubMed ID: 10096247
[TBL] [Abstract][Full Text] [Related]
18. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
Jin W; Xu X; Yang T; Hua Z
Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
[TBL] [Abstract][Full Text] [Related]
19. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathogenesis of malignant gliomas.
Rasheed BK; Wiltshire RN; Bigner SH; Bigner DD
Curr Opin Oncol; 1999 May; 11(3):162-7. PubMed ID: 10328589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
